Related Experiment Videos

Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I

M G Murray1, J Bradley, X F Yang

  • 1Department of Microbiology, School of Medicine, State University of New York, Stony Brook 11794.

Science (New York, N.Y.)
|July 8, 1988
PubMed

Insights

Poliovirus type 2 (Lansing) causes fatal disease in mice, unlike poliovirus type 1 (Mahoney). A specific amino acid sequence in antigenic site I is crucial for poliovirus host range and mouse neurovirulence.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Poliovirus type 2 (Lansing strain) is neurovirulent in mice, while type 1 (Mahoney strain) is not.
  • Previous studies linked viral capsid proteins and mutations in antigenic site I to reduced Lansing strain neurovirulence.

Purpose of the Study:

  • To investigate the role of poliovirus antigenic site I in mouse neurovirulence.
  • To construct and analyze an antigenic hybrid virus to understand host range determinants.

Main Methods:

  • Site-directed mutagenesis was used to replace six amino acids in antigenic site I of the Mahoney strain with the Lansing strain sequence.
  • The resulting hybrid virus was tested for neutralization by type-specific antisera and monoclonal antibodies.
  • The neurovirulence of the hybrid virus was assessed in mice following intracerebral inoculation.

Main Results:

  • The hybrid virus was neutralized by antibodies against both poliovirus type 1 and type 2.
  • The hybrid virus induced paralytic disease in mice, similar to the Lansing strain.
  • A short amino acid sequence in antigenic site I was identified as a key determinant of poliovirus host range.

Conclusions:

  • Antigenic site I plays a critical role in determining poliovirus host range and mouse neurovirulence.
  • This specific amino acid sequence may be involved in poliovirus attachment to mouse central nervous system cells.

Related Concept Videos